Cancer BiologybioRxivPreprint
CMAS dampens anti-tumor immunity and associates with response to neoadjuvant immunotherapy in melanoma
Magalí B. Coccimiglio, Sofia Ibáñez‐Molero, Babet O. Springer…·Yvette van Kooyk
The paper shows CMAS in melanoma cells correlates with poor survival and reduced response to immunotherapy by altering tumor-immune interactions.